ACT Genomics logo

ACT Genomics

Make Personalized Medicine Accessible To All.

121 employees · est. 2014 · Taiwan

VS
Svastia Genetics logo

Svastia Genetics

Precision genome analytics and novel patient data collections for improving cancer treatment outcomes

1 employees · est. 2019 · Cambridge, United Kingdom

ACT Genomics is the older company (2014 vs 2019); ACT Genomics is the larger of the two.

Side-by-Side Comparison

ACT Genomics Svastia Genetics
Founded
2014 older 2019
Headquarters
Taiwan Cambridge, United Kingdom
Employees
121 larger 1
Industry
Biotechnology, Health Care, Information Technology Analytics, Biotechnology, Data Analytics
Funding Stage
Series Unknown Seed
Total Funding
$20.50M Not tracked yet
Funding Rounds
4 Not tracked yet
Services
Not tracked yet Sequencing Services, Drug Efficacy Screening, Data Collection Services, Therapeutic Antibody Development, siRNA Target Finder
Target Customers
Not tracked yet Hospitals, Diagnostic Laboratories, Research Institutions, Pharmaceutical Companies, Clinical Research Organizations (CROs)
Taxonomy
Personalized Medicine, Genomic Testing, Precision Medicine, Cancer Genomics, Bioinformatics, NGS Platform, Cancer Monitoring, Immunotherapy Evaluation, Clinical Services, Cancer Prevention, Early Detection, Treatment Selection, Disease Monitoring, Oncology, Molecular Information Precision Genome Analytics, Clinical Decision Support, Cancer Treatment Selection, Relapse Prediction, Oncology Knowledgebase, Clinical Genomic Data, Genetic Analysis Workflows, Stratified Medicine, Genomic Data Analysis, Biomarker Pattern Discovery, Exome Data Analysis, RNA-seq Data Analysis, Omics Discoveries Reporting, Drug Sensitivity Screening, Oncology Clinical Trial Design
Website
actgenomics.com svastia.ai
ACT Genomics logo

About ACT Genomics

ACT Genomics is a world-leading genomic test solution provider founded in 2014 and headquartered in Taiwan. The company's slogan "Make Personalized Medicine Accessible To All" reflects its commitment to providing precision medicine services globally. ACT Genomics combines tumor biology, cancer genom...

Svastia Genetics logo

About Svastia Genetics

Svastia Genetics is a dynamic company specializing in precision genome analytics and novel patient data collections aimed at enhancing cancer treatment outcomes. Since its founding in 2019, the company has been at the forefront of combining clinical decision support with an expansive oncology knowle...

We will tell you when either one moves

BounceWatch watches ACT Genomics and Svastia Genetics for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.

Watch both — free

Funding, hiring, leadership and stack changes at ACT Genomics and Svastia Genetics — by email.

Frequently Asked Questions

ACT Genomics — Make Personalized Medicine Accessible To All.. Svastia Genetics — Precision genome analytics and novel patient data collections for improving cancer treatment outcomes. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
ACT Genomics has raised $20.50M while Svastia Genetics has raised undisclosed funding.
ACT Genomics and Svastia Genetics operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare ACT Genomics with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at ACT Genomics on 12 Sep 2024, and Svastia Genetics on 29 Apr 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

One analytics cookie (Google Analytics). Cookie Policy